Skip to content

ADMA Biologics ADMA Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin61.3%+8.7pp57.4%+5.9pp54.7%+5.8pp53%+6.9pp52.6%+13.2pp
Operating margin42.1%+9.0pp37.5%+4.9pp34.2%+4.2pp32.8%+7.4pp33.1%+17.5pp
Net margin32.4%-12.6pp28.8%-17.6pp42.9%+25.1pp44.1%+33.5pp45%+46.3pp
Returns
Return on equity43.3%-35.2pp35.6%-46.1pp63.2%+27.6pp71.2%+50.5pp78.5%+80.9pp
Return on invested capital44.8%-25.8pp38.6%-27.1pp54.9%-26.0pp72.6%+10.6pp70.7%+33.9pp
Efficiency
Asset turnover0.9×-0.2×0.9×-0.1×0.0×+0.1×1.1×+0.2×
Liquidity
Current ratio+0.4×6.7×+0.7×7.1×0.0×5.3×-1.5×6.6×+1.4×
Leverage
Debt-to-equity0.5×+0.5×0.2×-0.1×0.2×+0.1×0.0×0.0×
Net debt / EBITDA0.3×+0.7×-0×+0.1×0.1×+0.8×-0.5×+0.5×-0.4×+0.4×
Per Share
Book value per share$1.63+6.6%$1.95+35.9%$1.76+86.1%$1.60+106%$1.53+135%
Valuation
Market capitalization$2.15B-54.5%$4.34B+7.1%$3.5B-24.9%$4.26B+64.4%$4.71B+213%
Price / earnings13×-9.8×29.5×+9.0×16.7×-51.7×20.4×-54.1×22.8×
Price / sales4.2×-6.1×8.5×-1.0×7.2×-5.0×+1.1×10.3×+4.9×
Price / book5.5×-7.1×9.1×-2.5×8.1×-12.0×10.7×-3.1×12.6×+2.8×
EV / EBITDA9.9×-19.2×21.7×-5.8×20.1×-20.2×25.6×-6.1×29.1×-3.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ADMA Biologics's profit margins?
ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.
Where do ADMA Biologics's ratios come from?
Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.